Commission Finds Patent Abuse Falls Inside Art.82

The European Commission has flora AstraZeneca guilty of abusing its dominant lay on the marketplace for proton heart inhibitors yesteryear misusing the patent system. AZ provided faux data to the patent offices of a publish of European Union Member U.S. which led to AZ gaining extended patent protection for Losec through supplementary protection certificates. The presence of the SPCs meant that the patent offices did non seek whether Losce was innovative, equally they would unremarkably hold upward obliged to produce inward a patent claim. Once AZ had this extended patent protection, it used it anticompetitively inward guild to blocking or delay marketplace access for generic versions of Losec. AZ also used its dominant lay inward guild to preclude parallel importers from importing the drug.

thinks that the human relationship betwixt antitrust together with IP is poorly understood. He waits to come across what IP lawyers volition brand of this decision.

Proton heart inhibitors here